Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Clinical Practice Guideline: Tonsillectomy in Children (Update)-Executive Summary.

Mitchell RB, Archer SM, Ishman SL, Rosenfeld RM, Coles S, Finestone SA, Friedman NR, Giordano T, Hildrew DM, Kim TW, Lloyd RM, Parikh SR, Shulman ST, Walner DL, Walsh SA, Nnacheta LC.

Otolaryngol Head Neck Surg. 2019 Feb;160(2):187-205. doi: 10.1177/0194599818807917.

PMID:
30921525
2.

Clinical Practice Guideline: Tonsillectomy in Children (Update).

Mitchell RB, Archer SM, Ishman SL, Rosenfeld RM, Coles S, Finestone SA, Friedman NR, Giordano T, Hildrew DM, Kim TW, Lloyd RM, Parikh SR, Shulman ST, Walner DL, Walsh SA, Nnacheta LC.

Otolaryngol Head Neck Surg. 2019 Feb;160(1_suppl):S1-S42. doi: 10.1177/0194599818801757.

PMID:
30798778
3.

DRESS Following FIRES: A Clinical Conundrum.

Dahl AR, Knoebel EE, Lloyd RM.

Clin Pediatr (Phila). 2018 Oct;57(12):1479-1482. doi: 10.1177/0009922818787321. Epub 2018 Jul 16. No abstract available.

PMID:
30010401
4.

AASM Scoring Manual Updates for 2017 (Version 2.4).

Berry RB, Brooks R, Gamaldo C, Harding SM, Lloyd RM, Quan SF, Troester MT, Vaughn BV.

J Clin Sleep Med. 2017 May 15;13(5):665-666. doi: 10.5664/jcsm.6576. No abstract available.

5.

Pediatric Sleep Duration Consensus Statement: A Step Forward.

Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, Malow BA, Maski K, Nichols C, Quan SF, Rosen CL, Troester MM, Wise MS.

J Clin Sleep Med. 2016 Dec 15;12(12):1705-1706. doi: 10.5664/jcsm.6368. No abstract available.

6.

Consensus Statement of the American Academy of Sleep Medicine on the Recommended Amount of Sleep for Healthy Children: Methodology and Discussion.

Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, Malow BA, Maski K, Nichols C, Quan SF, Rosen CL, Troester MM, Wise MS.

J Clin Sleep Med. 2016 Nov 15;12(11):1549-1561.

7.

Depression, anxiety, and tobacco use: Overlapping impediments to sleep in a national sample of college students.

Boehm MA, Lei QM, Lloyd RM, Prichard JR.

J Am Coll Health. 2016 Oct;64(7):565-74. doi: 10.1080/07448481.2016.1205073. Epub 2016 Jun 27.

PMID:
27347758
8.

Recommended Amount of Sleep for Pediatric Populations: A Consensus Statement of the American Academy of Sleep Medicine.

Paruthi S, Brooks LJ, D'Ambrosio C, Hall WA, Kotagal S, Lloyd RM, Malow BA, Maski K, Nichols C, Quan SF, Rosen CL, Troester MM, Wise MS.

J Clin Sleep Med. 2016 Jun 15;12(6):785-6. doi: 10.5664/jcsm.5866.

9.

AASM Scoring Manual Version 2.2 Updates: New Chapters for Scoring Infant Sleep Staging and Home Sleep Apnea Testing.

Berry RB, Gamaldo CE, Harding SM, Brooks R, Lloyd RM, Vaughn BV, Marcus CL.

J Clin Sleep Med. 2015 Nov 15;11(11):1253-4. doi: 10.5664/jcsm.5176. No abstract available.

10.

Should the arousal scoring rule be changed?

Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaughn BV.

J Clin Sleep Med. 2015 Apr 15;11(4):497-9. doi: 10.5664/jcsm.4618. No abstract available.

11.

Quality measures for the care of pediatric patients with obstructive sleep apnea.

Kothare SV, Rosen CL, Lloyd RM, Paruthi S, Thomas SM, Troester MM, Carden KA.

J Clin Sleep Med. 2015 Mar 15;11(3):385-404. doi: 10.5664/jcsm.4558.

12.

HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Kantor R, DeLong A, Balamane M, Schreier L, Lloyd RM Jr, Injera W, Kamle L, Mambo F, Muyonga S, Katzenstein D, Hogan J, Buziba N, Diero L.

J Int AIDS Soc. 2014 Nov 18;17:19262. doi: 10.7448/IAS.17.1.19262. eCollection 2014.

13.

Comorbidities in infants with obstructive sleep apnea.

Qubty WF, Mrelashvili A, Kotagal S, Lloyd RM.

J Clin Sleep Med. 2014 Nov 15;10(11):1213-6. doi: 10.5664/jcsm.4204.

14.

Adolescent fatigue, POTS, and recovery: a guide for clinicians.

Kizilbash SJ, Ahrens SP, Bruce BK, Chelimsky G, Driscoll SW, Harbeck-Weber C, Lloyd RM, Mack KJ, Nelson DE, Ninis N, Pianosi PT, Stewart JM, Weiss KE, Fischer PR.

Curr Probl Pediatr Adolesc Health Care. 2014 May-Jun;44(5):108-33. doi: 10.1016/j.cppeds.2013.12.014. Review.

15.

Acute liver failure secondary to niacin toxicity.

Ellsworth MA, Anderson KR, Hall DJ, Freese DK, Lloyd RM.

Case Rep Pediatr. 2014;2014:692530. doi: 10.1155/2014/692530. Epub 2014 Feb 12.

16.

Perimenopause: counting sheep and still no sleep.

Lloyd RM, Files JA, Mayer AP.

J Womens Health (Larchmt). 2012 Nov;21(11):1209-10. doi: 10.1089/jwh.2012.3939. Epub 2012 Oct 9. No abstract available.

PMID:
23046045
17.

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.

Winters MA, Lloyd RM Jr, Shafer RW, Kozal MJ, Miller MD, Holodniy M.

PLoS One. 2012;7(7):e40514. doi: 10.1371/journal.pone.0040514. Epub 2012 Jul 18.

18.

Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection.

Zanoni M, Giron LB, Vilhena C, Sucupira MC, Lloyd RM Jr, Diaz RS.

J Clin Microbiol. 2012 Jan;50(1):145-7. doi: 10.1128/JCM.01016-11. Epub 2011 Oct 19.

19.

Comparative effectiveness of dried plasma HIV-1 viral load testing in Brazil using ViveST for sample collection.

Zanoni M, Cortes R, Diaz RS, Sucupira MC, Ferreira D, Inocencio LA, Vilhena C, Loveday C, Lloyd RM Jr, Holodniy M.

J Clin Virol. 2010 Dec;49(4):245-8. doi: 10.1016/j.jcv.2010.08.017. Epub 2010 Sep 29.

PMID:
20880740
20.

Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing.

Lloyd RM Jr, Burns DA, Huong JT, Mathis RL, Winters MA, Tanner M, De La Rosa A, Yen-Lieberman B, Armstrong W, Taege A, McClernon DR, Wetshtein JL, Friedrich BM, Ferguson MR, O'Brien W, Feorino PM, Holodniy M.

J Clin Microbiol. 2009 May;47(5):1491-6. doi: 10.1128/JCM.02354-08. Epub 2009 Mar 25.

21.

The clinical utility of enhanced subtelomeric coverage in array CGH.

Ballif BC, Sulpizio SG, Lloyd RM, Minier SL, Theisen A, Bejjani BA, Shaffer LG.

Am J Med Genet A. 2007 Aug 15;143A(16):1850-7.

PMID:
17632771
22.

Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase.

Kagan RM, Lee TS, Ross L, Lloyd RM Jr, Lewinski MA, Potts SJ.

Antiviral Res. 2007 Sep;75(3):210-8. Epub 2007 Apr 4.

PMID:
17442410
23.

Development of a high-density pericentromeric region BAC clone set for the detection and characterization of small supernumerary marker chromosomes by array CGH.

Ballif BC, Hornor SA, Sulpizio SG, Lloyd RM, Minier SL, Rorem EA, Theisen A, Bejjani BA, Shaffer LG.

Genet Med. 2007 Mar;9(3):150-62.

PMID:
17413419
24.

Tailored catalysts for plant cell-wall degradation: redesigning the exo/endo preference of Cellvibrio japonicus arabinanase 43A.

Proctor MR, Taylor EJ, Nurizzo D, Turkenburg JP, Lloyd RM, Vardakou M, Davies GJ, Gilbert HJ.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2697-702. Epub 2005 Feb 11.

25.

Cloning and characterization of arabinoxylan arabinofuranohydrolase-D3 (AXHd3) from Bifidobacterium adolescentis DSM20083.

van den Broek LA, Lloyd RM, Beldman G, Verdoes JC, McCleary BV, Voragen AG.

Appl Microbiol Biotechnol. 2005 Jun;67(5):641-7. Epub 2005 Jan 14.

PMID:
15650848
26.

Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.

Kuritzkes DR, Grant RM, Feorino P, Griswold M, Hoover M, Young R, Day S, Lloyd RM Jr, Reid C, Morgan GF, Winslow DL.

J Clin Microbiol. 2003 Apr;41(4):1594-9.

27.

Accuracy of the TRUGENE HIV-1 genotyping kit.

Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, Swanstrom R, D'Aquila RT, Van Gorder M, Holodniy M, Lloyd RM Jr, Reid C, Morgan GF, Winslow DL.

J Clin Microbiol. 2003 Apr;41(4):1586-93.

28.

Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns.

Parker MM, Wade N, Lloyd RM Jr, Birkhead GS, Gallagher BK, Cheku B, Sullivan T, Taylor J.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):292-7.

PMID:
12626889
29.

The structure of S100A12 in a hexameric form and its proposed role in receptor signalling.

Moroz OV, Antson AA, Dodson EJ, Burrell HJ, Grist SJ, Lloyd RM, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB.

Acta Crystallogr D Biol Crystallogr. 2002 Mar;58(Pt 3):407-13. Epub 2002 Feb 21.

PMID:
11856825
30.

Characterization of Escherichia coli OtsA, a trehalose-6-phosphate synthase from glycosyltransferase family 20.

Gibson RP, Lloyd RM, Charnock SJ, Davies GJ.

Acta Crystallogr D Biol Crystallogr. 2002 Feb;58(Pt 2):349-51. Epub 2002 Jan 24.

PMID:
11807274
31.

Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.

Tang YW, Huong JT, Lloyd RM Jr, Spearman P, Haas DW.

J Clin Microbiol. 2000 Dec;38(12):4637-9.

32.

Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.

Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR, Fletcher CV, Fiscus S, Raffanti S, Donlon R, McKinsey J, Nicotera J, Schmidt D, Shoup RE, Kates RE, Lloyd RM Jr, Larder B.

AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1491-502.

PMID:
11054262
33.
34.

Cloning and expression of sporozoite and oocyst Cryptosporidium parvum recombinant proteins.

Bonafonte MT, Lloyd RM Jr, Garmon KD, You X, Arrowood MJ, Schinazi RF, Mead JR.

J Eukaryot Microbiol. 1996 Sep-Oct;43(5):83S. No abstract available.

PMID:
8822875
35.

Carboranyl oligonucleotides. 3. Biochemical properties of oligonucleotides containing 5-(o-carboranyl-1-yl)-2'-deoxyuridine.

Lesnikowski ZJ, Fulcrand G, Lloyd RM Jr, Juodawlkis A, Schinazi RF.

Biochemistry. 1996 May 7;35(18):5741-6.

PMID:
8639534
36.

The "trickle-down effect" of dental implants.

Lloyd RM.

J Prosthodont. 1995 Mar;4(1):1. No abstract available.

PMID:
7670604
37.

Isolation and partial characterization of Cryptosporidium sporozoite and oocyst wall recombinant proteins.

Mead JR, Lloyd RM Jr, You X, Tucker-Burden C, Arrowood MJ, Schinazi RF.

J Eukaryot Microbiol. 1994 Sep-Oct;41(5):51S. No abstract available.

PMID:
7804255
38.

Antiviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase occur in specific RNA structural regions.

Schinazi RF, Lloyd RM Jr, Ramanathan CS, Taylor EW.

Antimicrob Agents Chemother. 1994 Feb;38(2):268-74.

39.

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides.

Schinazi RF, Lloyd RM Jr, Nguyen MH, Cannon DL, McMillan A, Ilksoy N, Chu CK, Liotta DC, Bazmi HZ, Mellors JW.

Antimicrob Agents Chemother. 1993 Apr;37(4):875-81.

41.

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

Schinazi RF, McMillan A, Cannon D, Mathis R, Lloyd RM, Peck A, Sommadossi JP, St Clair M, Wilson J, Furman PA, et al.

Antimicrob Agents Chemother. 1992 Nov;36(11):2423-31.

42.
43.

Effect of cortisone administration on host-parasite relationships in early experimental syphilis.

Lukehart SA, Baker-Zander SA, Lloyd RM, Sell S.

J Immunol. 1981 Oct;127(4):1361-8. No abstract available.

PMID:
7024407
44.
46.

Marine dolomite of unusual isotopic composition.

Russell KL, Deffeyes KS, Fowler GA, Lloyd RM.

Science. 1967 Jan 13;155(3759):189-91.

PMID:
17738221

Supplemental Content

Loading ...
Support Center